3rd Synthetic Biology Based Therapeutics Summit
When:
Monday, Dec 04, 2023 9:00a -
Wednesday, Dec 06, 2023 5:15p
Monday, Dec 04, 2023 9:00a -
Wednesday, Dec 06, 2023 5:15p
Where:
Boston Park Plaza
50 Park Plaza
Boston, Massachusetts 02116
Admission:
$2199.00 - $5297.00
Hosted by:
Categories:
Lectures & Conferences
Event website:
https://go.evvnt.com/1904088-0?pid=5248
From personalized therapies to precise drug delivery systems, synthetic biology offers the chance to revolutionize diagnostics, treatment, and even disease prevention, ushering in a new era of medical possibilities that hold the potential to reshape human health and well-being.
Join us in harnessing the potential of this nascent, modality-agnostic field brimming with cutting-edge technology, from case studies on optimized drug delivery mechanisms to proteomics and analytical strategies, we're offering a panoramic view of the future.
The Synthetic Biology-Based Therapeutics Summit is your only opportunity to keep up with the latest research, bridge the gap between academia and industry and help support your internal discovery and translational development strategy – we hope to see your team in December!
URLs:
Tickets: https://go.evvnt.com/1904088-2?pid=5248
Brochure: https://go.evvnt.com/1904088-3?pid=5248
Prices:
Industry | Conference + Workshop Day: USD 3597.00,
Industry | Conference Only: USD 2599.00,
Academic | Conference + Workshop Day: USD 3097.00,
Academic | Conference Only: USD 2199.00,
Vendor | Conference + Workshop Day: USD 5297.00,
Vendor | Conference Only: USD 3799.00
Speakers: Anders Lund | Director, Analytical Development | Synlogic, Brian Garrison | Senior Director of Research | Senti Biosciences Inc., Casey Lippmeier | Senior Vice President, Innovation | Conagen Inc, Christopher Raggio | Angel Investor | Raggio Capital, Gregory Linshiz | Associate Director - Synthetic Biology | Replay, Jamie Spangler | Assistant Professor, Biomedical Chemical and Biomolecular Engineering | Johns Hopkins, Jason Kelly | Founder and Chief Executive Officer | Ginkgo Bioworks Inc., Jaspreet Khurana | Director, Platform and Discovery | Strand Therapeutics Inc., Jodi Barrientos | Chief Business Officer | Ribbon Biolabs, Jonathan Winkler | Senior Director - Analytical Development | Seres Therapeutics, Kyle Daniels | Assistant Professor of Genetics | Stanford University, Marc Guell | Co-Founder and Scientific Head | Integra Therapeutics, Mo Ebrahimkhani | Associate Professor and Director, Laboratory Synthetic Morphogenetics and Tissue Ecology | University of Pittsburgh, Qi Cai | Director of Cell Biology | Kite Pharma Inc, Ron Weiss | Professor | MIT, Sean McClain | Chief Executive Officer and Founder | AbSci, Stella Khiew | Senior Scientist | Merck and Co, Steve Santoro | Senior Director, Translational Sciences | Arsenal Bio, Stuart Licht | Scientific Director of Protein Science | Moderna, Vinit Nijhawan | Managing Director | MassVentures, Xavier Duportet | Co-founder and Chief Executive Officer | Eligo Bioscience, Xiaohua Wang | Director - Cell Therapy Application and Integrative Science | Bristol Myers Squibb, Xiaojing Gao | Assistant Professor Department of Chemical Engineering | Stanford University
